Skip to content
lifestyle.celebhomes.net
Author:
Mineralys Therapeutics, Inc.
Mineralys Therapeutics to Announce Fourth Quarter and Full Year 2025 Financial Results and Host Conference Call on Thursday, March 12, 2026
March 26, 2026
Mineralys Therapeutics Appoints Jeffrey A. Munsie as Chief Legal Officer
March 24, 2026
Mineralys Therapeutics Announces FDA Acceptance of NDA for Lorundrostat for Treatment of Adults with Hypertension and Topline Explore-OSA Trial Results
March 9, 2026
←
Previous Page
1
2
3